Perbedaan Bekasi Asri Pemula Tbk dan Brigit Biofarmaka Teknologi Tbk.: Bekasi Asri Pemula Tbk diperdagangkan di Rp145 (kapitalisasi pasar 99,93 M, volume 24 jam 6,55 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Bekasi Asri Pemula Tbk lebih aktif diperdagangkan (6,55 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BAPA | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 99,93 M | 164,65 M |
Volume | 6,55 jt | 187,4 rb |
Lot | 65,5 rb | 1,87 rb |
Perputaran | 969,81 jt | 44,35 jt |
Harga Rata-rata | 148,07 | 236,67 |
Nilai Transaksi | 969,81 jt | 44,35 jt |
Harga Ekuilibrium Indikatif | 145 | 242 |
Volume Ekuilibrium Indikatif | 880 | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.
Selengkapnya di halaman BAPA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →